Madeleine Johnson

Editor

Phone Number

+1-212-651-5639

Email

mjohnson@genomeweb.com

Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.

Articles Authored by Madeleine Johnson

Sep 30, 2019

Q&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics

Premium

The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.

Sep 27, 2019

Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth

Premium

New outcomes data shows that the firm's test can help clinicians optimize antibiotic prescribing, but investment analysts have had mixed reactions.

Sep 25, 2019

With C. Auris Proliferating, NYSDOH Wadsworth Center to Fund Device Development for POC Tests

Premium

For the first time ever, the center is funding the development of diagnostic systems — specifically for the development of three devices to detect the infection.

Sep 13, 2019

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

Premium

Based in Warsaw, Poland, the technology was inspired by "ultra-fast" PCR methods from the Wittwer group and Scope plans to launch tests for MRSA and C. diff.

Sep 13, 2019

BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

Premium

While the news of the BARDA contract drove a surge in T2's stock price, it was last month's NTAP decision that has company officials and analysts encouraged.

Sep 06, 2019

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Premium

New resistance tests for Mycoplasma genitalium and gonorrhea could help stave off superbugs, but guidelines and economic factors may hinder adoption.

Aug 30, 2019

Transcriptome-Based HPV Assay Shows Correlation With High-Grade Cytology

Premium

The new test uses the number of sequencing reads at specific early and late HPV transcripts as a biomarker for high-grade cytology.

Aug 27, 2019

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Premium

The clearance of the Binx io CT/NG test marks a milestone for the Johns Hopkins University group that funds early-stage development of rapid STI testing.

Aug 21, 2019

Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program

Premium

The company provided updates on its newborn screening testing presence.

Aug 20, 2019

OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests

Premium

The firm provided updates on its bacterial pathogen detection and antimicrobial resistance testing for bacterial isolates and a direct-from-urine test.

Menu

Madeleine Johnson

Q&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics

Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth

With C. Auris Proliferating, NYSDOH Wadsworth Center to Fund Device Development for POC Tests

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow

Transcriptome-Based HPV Assay Shows Correlation With High-Grade Cytology

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance

Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program

OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests

Breaking News

Avellino Labs Gets CLIA Certification

Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

William Blair, Cowen Initiate Coverage of Exagen

Novigenix, RadioMedix to Develop Neuroendocrine Cancer MDx

Yourgene Health H1 2019 Revenues Double

Germany's Dekra Becomes First Notified Body Designated Under New IVDR

Sponsorships